Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
adderall xr
- Development stage
- Approved
- Lead developer
- Takeda
- Modality
- Drug Delivery Systems, Small Molecules
- Administration
- Oral
01
Overview
Adderall XR is a central nervous system (CNS) stimulant medication formulated as an extended-release capsule containing four different amphetamine salts: dextroamphetamine saccharate, dextroamphetamine sulfate, amphetamine aspartate monohydrate, and amphetamine sulfate. It is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in adults and children aged 6 years and older. The drug works primarily by increasing synaptic concentrations of dopamine and norepinephrine through inhibition of their reuptake into presynaptic neurons. This action enhances neurotransmission in brain regions involved in attention and impulse control. Adderall XR provides a double-pulsed delivery system for prolonged therapeutic effect throughout the day[1][2][4][5].
- Brand names
- Adderall XR
- Other names
- amphetamine and dextroamphetamine extended-releasemixed amphetamine salts extended-releaseamphetamine salt combo XR
02
Targets
SERT (Sodium-dependent serotonin transporter)TAAR1 (Trace amine-associated receptor 1)DAT (Dopamine plasma membrane transport protein)VMAT2 (Vesicular monoamine transporter 2)MAOA (Monoamine oxidase A)NET (Norepinephrine Transporter)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))
Beyond the preview
Go deeper on adderall xr.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on adderall xr.